Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2011 Aug 26;142(5):1143–1151. doi: 10.1016/j.jtcvs.2011.07.051

Table 2.

Baseline Patient Characteristics

SR
(N=114)
SRB
(N=108)
p value*
Age 0.37**
   Median (Range) 70 (49–85) 72 (50–87)
Sex 0.72
   Female 65 (57%) 59 (55%)
   Male 49 (43%) 49 (45%)
Ethnicity 0.16
   Hispanic or Latino 0 (0%) 2 (1.9%)
   Not Hispanic or Latino 104 (91%) 91 (84%)
   Unknown 10 (9%) 15 (14%)
Race 0.42
   White 107 (93.9%) 103 (95.4%)
   Black or African American 7 (6.1%) 4 (3.7%)
   Unknown 0 (0%) 1 (0.9%)
Baseline Performance Status 0.56
   0 20 (17.5%) 25 (23.1%)
   1 66 (57.9%) 60 (55.6%)
   2 28 (24.6%) 23 (21.3%)
T Stage 0.12
   T1 114 (100%) 104 (96.3%)
   T2 0 (0%) 3 (2.8%)
   T3 0 (0%) 1 (0.9%)
M Stage NA
   M0 114 (100%) 108 (100%)
N Stage 0.37
   N0 113 (99.1%) 107 (99.1%)
   N1 0 (0%) 1 (0.9%)
   N2 1 (0.9%) 0 (0%)
Surgery in Upper Lobe 0.07
   No 38 (33.3%) 49 (45.4%)
   Yes 76 (66.7%) 59 (54.6%)
Surgery Type
   VATS 79 (69.3%) 65 (60.2%) 0.16
   Thoracotomy 35 (30.7%) 43 (39.8%)
Surgery extent 0.29
   Segmentectomy 38 (33.3%) 29 (26.9%)
   Wedge Resection 76 (66.7%) 79 (73.1%)
ASA class (III/IV vs. I/II) on surgery day*** 0.02
   I/II 10 (8.8%) 21 (19.8%)
   III/IV 104 (91.2%) 85 (80.2%)
Baseline DLCO% 0.36**
   N 111 106
   Median (Range) 47 (18–97) 44 (8–137)
Baseline FEV1% 0.25**
   N 114 107
   Median (Range) 48 (22–117) 53 (25–110)

SR= Sublobar Resection; SRB=Sublobar Resection with Intraoperative Brachytherapy

*

Chi-square test;

**

Wilcoxon rank sum test;

***

Excludes 2 SRB with missing data